EGFR and liver cancer: ICC, an aggressive primary liver cancer with a low but clearly documented increase in incidence and mortality [8], is characterized by frequent over-expression of epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF), as well as other pro-angiogenic and hypoxia mediators [9–14].